99 related articles for article (PubMed ID: 15365314)
1. Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease.
Gonzalez-Quintela A; Mella C; Abdulkader I; Perez LF; Campos J; Otero E; Forteza J
Alcohol Clin Exp Res; 2004 Sep; 28(9):1413-8. PubMed ID: 15365314
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.
Gonzalez-Quintela A; García J; Campos J; Perez LF; Alende MR; Otero E; Abdulkader I; Tomé S
Alcohol; 2006 Jan; 38(1):45-9. PubMed ID: 16762691
[TBL] [Abstract][Full Text] [Related]
3. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis.
González-Quintela A; Mella C; Pérez LF; Abdulkader I; Caparrini AM; Lojo S
Alcohol Clin Exp Res; 2000 Aug; 24(8):1222-6. PubMed ID: 10968661
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases.
Gonzalez-Quintela A; Mallo N; Mella C; Campos J; Perez LF; Lopez-Rodriguez R; Tome S; Otero E
Liver Int; 2006 Dec; 26(10):1217-24. PubMed ID: 17105587
[TBL] [Abstract][Full Text] [Related]
5. A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins.
Van Eyken P; Sciot R; Desmet VJ
Histopathology; 1988 Dec; 13(6):605-17. PubMed ID: 2466751
[TBL] [Abstract][Full Text] [Related]
6. Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease.
Ray MB; Mendenhall CL; French SW; Gartside PS
Hepatology; 1988; 8(5):1019-26. PubMed ID: 2458308
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis.
Gonzalez-Quintela A; Abdulkader I; Campos J; Fernandez-Hernandez L; Lojo S
Dig Dis Sci; 2009 Mar; 54(3):648-53. PubMed ID: 18618253
[TBL] [Abstract][Full Text] [Related]
8. Distribution patterns of cytokeratin antigen determinants in alcoholic and nonalcoholic liver diseases.
Ray MB
Hum Pathol; 1987 Jan; 18(1):61-6. PubMed ID: 2434406
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin inclusions in alcoholic liver disease and their relation to the amount of alcohol intake.
Savolainen VT; Lalu K; Penttilä A; Virtanen I; Karhunen PJ
Liver; 1994 Dec; 14(6):281-7. PubMed ID: 7533231
[TBL] [Abstract][Full Text] [Related]
10. De novo expression of nonhepatocellular cytokeratins in Mallory body formation.
Schirmacher P; Dienes HP; Moll R
Virchows Arch; 1998 Feb; 432(2):143-52. PubMed ID: 9504859
[TBL] [Abstract][Full Text] [Related]
11. Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.
Lavallard VJ; Bonnafous S; Patouraux S; Saint-Paul MC; Rousseau D; Anty R; Le Marchand-Brustel Y; Tran A; Gual P
PLoS One; 2011 Mar; 6(3):e17599. PubMed ID: 21445263
[TBL] [Abstract][Full Text] [Related]
12. Increased urinary levels of tissue polypeptide specific antigen (TPS) in alcoholics.
Barros P; Gonzalez-Quintela A; Mella C; Perez LF
Anticancer Res; 2006; 26(2B):1531-4. PubMed ID: 16619568
[TBL] [Abstract][Full Text] [Related]
13. The common pattern of cytokeratin alteration in alcoholic and cholestatic liver disease is different from that of hepatitic liver damage. A study with the panepithelial monoclonal antibody lu-5.
Müllhaupt B; Gudat F; Epper R; Bianchi L
J Hepatol; 1993 Aug; 19(1):23-35. PubMed ID: 7507954
[TBL] [Abstract][Full Text] [Related]
14. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease.
van Dalen A
Anticancer Res; 1996; 16(4B):2345-9. PubMed ID: 8694567
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS.
Pujol JL; Grenier J; Parrat E; Lehmann M; Lafontaine T; Quantin X; Michel FB
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):725-33. PubMed ID: 8810612
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?
Nisman B; Lafair J; Heching N; Lyass O; Baras M; Peretz T; Barak V
Cancer; 1998 May; 82(10):1850-9. PubMed ID: 9587116
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.
Tarantino G; Conca P; Coppola A; Vecchione R; Di Minno G
Eur J Clin Invest; 2007 Jan; 37(1):48-53. PubMed ID: 17181567
[TBL] [Abstract][Full Text] [Related]
18. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C
Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin markers in patients with prostatic diseases.
Wolff JM; Borchers H; Brehmer B; Brauers A; Jakse G
Anticancer Res; 1999; 19(4A):2649-52. PubMed ID: 10470212
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide-specific antigen in renal cell carcinoma.
Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
